Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue

Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue

Objective:Binding to angiotensin-converting enzyme 2 (ACE2) receptor is a critical step for severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) to mediate its entry into target cells. ACE2 is expressed in many human tissues, including the lungs. However, no research has demonstrated that SA...

Full description

Bibliographic Details
Main Author:	Sammy Al-Benna
Format:	Article
Language:	English
Published:	Galenos Publishing House 2021-04-01
Series:	European Journal of Breast Health
Subjects:	breast angiotensin converting enzyme 2 gene expression coronavirus severe acute respiratory syndrome coronavirus 2 covid-19
Online Access:	http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/iangiotensin-converting-enzyme-2-i-gene-expression/47119

Similar Items

Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A singlecenter cohort study
by: Serdal Baştuğ, et al.
Published: (2022-02-01)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
by: Meng-Yuan Liu, et al.
Published: (2020-06-01)

Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients
by: Nayara Azinheira Nobrega Cruz, et al.
Published: (2021-08-01)

mRNA expression of the severe acute respiratory syndrome-coronavirus 2 angiotensin-converting enzyme 2 receptor in the lung tissue of Wistar rats according to age
by: Hazem Almhanna, et al.
Published: (2022-02-01)

Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
by: Sang Heon Suh, et al.
Published: (2021-03-01)

Research progress on the expression and distribution of severe acute respiratory syndrome coronavirus 2 receptor angiotensin-converting enzyme 2 in ocular tissues
by: Yu-Sheng Zhu, et al.
Published: (2023-06-01)

Angiotensin-Converting Enzymes, the Key Components in the Pathogenesis of COVID-19 Infection and their Role in the Interaction of SARS-Cov-2 with Human Host Cells
by: Seyed Mehdi Hoseini, et al.
Published: (2022-05-01)

Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor
by: Noor S Hameed, et al.
Published: (2023-01-01)

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
by: Jordan Swiderski, et al.
Published: (2023-05-01)

Patients with severe COVID‐19 have reduced circulating levels of angiotensin‐(1–7): A cohort study
by: Seyed Mohammad Seyedmehdi, et al.
Published: (2022-03-01)

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth
by: Kunal Bikram Shaha, et al.
Published: (2020-05-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Ilaria Caputo, et al.
Published: (2022-05-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
by: Amanj Kurdi, et al.
Published: (2020-12-01)

Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index
by: Lars Jehpsson, et al.
Published: (2021-01-01)

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
by: Daniel Caldeira, et al.
Published: (2020-12-01)

The Potential of the Use of the Flavonoid Fisetin in the Treatment of Coronavirus by Inhibition of Angiotensin Converting Enzyme 2
by: Seyedeh Sara Azadeh, et al.
Published: (2021-11-01)

ACE2 Shedding and the Role in COVID-19
by: Jieqiong Wang, et al.
Published: (2022-01-01)

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection <italic toggle="yes">In Vitro</italic>
by: Francesca Curreli, et al.
Published: (2020-12-01)

Assessment and strategy development for SARS-CoV-2 screening in wildlife: A review
by: Jignesh Italiya, et al.
Published: (2023-06-01)

Exploring the causes of mild COVID-19 involvement in pediatric patients
by: A. Naserghandi, et al.
Published: (2020-09-01)

NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments
by: Simona Damiano, et al.
Published: (2020-12-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
by: Sanju Sinha, et al.
Published: (2020-07-01)

Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
by: Zhonglin Li, et al.
Published: (2020-10-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review
by: Apichet Sirinawasatien, et al.
Published: (2021-11-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome
by: Akram Khan, et al.
Published: (2017-09-01)

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19
by: Polina O. Shatunova, et al.
Published: (2020-09-01)

Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications
by: En-Chin Lin, et al.
Published: (2023-10-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

The Mechanisms and Animal Models of SARS-CoV-2 Infection
by: Wenrui Jia, et al.
Published: (2021-04-01)

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
by: Yu-Huang Liao, et al.
Published: (2020-12-01)

COVID-19 and the lungs: A review
by: Wen-Lin Su, et al.
Published: (2021-11-01)

Obesity and COVID-19 Pandemics: Epidemiology, Mechanisms, and Management
by: Yang Y, et al.
Published: (2023-12-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)